NCT03935464View on ClinicalTrials.gov

Point-of-care Urine Monitoring of Adherence: Testing a Real-Time Urine Assay of Tenofovir in PrEP

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Risk Reduction
Interventions
BEHAVIORAL

PUMA

Collect urine on intervention participants and screen for presence of TFV. Feedback will be provided to the participant based on the results on their adherence with provision of standard adherence counseling.

Trial Locations (1)

Unknown

KEMRI Partners in Health and Research Development (PHRD), Thika, Thika

Sponsors
All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

collaborator

University of Washington

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of California, San Francisco

OTHER